You can:
Name | Succinate receptor 1 |
---|---|
Species | Homo sapiens (Human) |
Gene | SUCNR1 |
Synonym | succinate receptor 1 succinate receptor P2Y purinoceptor 1-like P2Y purinoceptor 1 GPR91 [ Show all ] |
Disease | N/A |
Length | 334 |
Amino acid sequence | MLGIMAWNATCKNWLAAEAALEKYYLSIFYGIEFVVGVLGNTIVVYGYIFSLKNWNSSNIYLFNLSVSDLAFLCTLPMLIRSYANGNWIYGDVLCISNRYVLHANLYTSILFLTFISIDRYLIIKYPFREHLLQKKEFAILISLAIWVLVTLELLPILPLINPVITDNGTTCNDFASSGDPNYNLIYSMCLTLLGFLIPLFVMCFFYYKIALFLKQRNRQVATALPLEKPLNLVIMAVVIFSVLFTPYHVMRNVRIASRLGSWKQYQCTQVVINSFYIVTRPLAFLNSVINPVFYFLLGDHFRDMLMNQLRHNFKSLTSFSRWAHELLLSFREK |
UniProt | Q9BXA5 |
Protein Data Bank | N/A |
GPCR-HGmod model | Q9BXA5 |
3D structure model | This predicted structure model is from GPCR-EXP Q9BXA5. |
BioLiP | N/A |
Therapeutic Target Database | N/A |
ChEMBL | CHEMBL2150838 |
IUPHAR | 166 |
DrugBank | BE0002258 |
Name | D0GC5Y |
---|---|
Molecular formula | C25H23ClF3N5O3 |
IUPAC name | N-[4-[5-[3-chloro-4-(trifluoromethoxy)phenyl]-1,3,4-oxadiazol-2-yl]butyl]-4-(1,8-naphthyridin-2-yl)butanamide |
Molecular weight | 533.936 |
Hydrogen bond acceptor | 10 |
Hydrogen bond donor | 1 |
XlogP | 5.4 |
Synonyms | N-(4-{5-[3-chloro-4-(trifluoromethoxy)phenyl]-1,3,4-oxadiazol-2-yl}butyl)-4-(1,8-naphthyridin-2-yl)butanamide GTPL5515 compound 7e [PMID: 21571530] |
Inchi Key | RCSBCWXPGSPJNF-UHFFFAOYSA-N |
Inchi ID | InChI=1S/C25H23ClF3N5O3/c26-19-15-17(10-12-20(19)37-25(27,28)29)24-34-33-22(36-24)8-1-2-13-30-21(35)7-3-6-18-11-9-16-5-4-14-31-23(16)32-18/h4-5,9-12,14-15H,1-3,6-8,13H2,(H,30,35) |
PubChem CID | 73755126 |
ChEMBL | N/A |
IUPHAR | 5515 |
BindingDB | N/A |
DrugBank | N/A |
Structure | |
Lipinski's druglikeness | This ligand is heavier than 500 daltons. This ligand has a partition coefficient log P greater than 5. |
Parameter | Value | Reference | Database source |
---|---|---|---|
IC50 | 180.0 nM | PMID21571530 | IUPHAR |
zhanglabzhanggroup.org | +65-6601-1241 | Computing 1, 13 Computing Drive, Singapore 117417